These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30107448)

  • 1. Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.
    Ozguler Y; Leccese P; Christensen R; Esatoglu SN; Bang D; Bodaghi B; Çelik AF; Fortune F; Gaudric J; Gul A; Kötter I; Mahr A; Moots RJ; Richter J; Saadoun D; Salvarani C; Scuderi F; Sfikakis PP; Siva A; Stanford M; Tugal-Tutkun I; West R; Yurdakul S; Olivieri I; Yazici H; Hatemi G
    Rheumatology (Oxford); 2018 Dec; 57(12):2200-2212. PubMed ID: 30107448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2018 update of the EULAR recommendations for the management of Behçet's syndrome.
    Hatemi G; Christensen R; Bang D; Bodaghi B; Celik AF; Fortune F; Gaudric J; Gul A; Kötter I; Leccese P; Mahr A; Moots R; Ozguler Y; Richter J; Saadoun D; Salvarani C; Scuderi F; Sfikakis PP; Siva A; Stanford M; Tugal-Tutkun I; West R; Yurdakul S; Olivieri I; Yazici H
    Ann Rheum Dis; 2018 Jun; 77(6):808-818. PubMed ID: 29625968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
    Hatemi I; Hatemi G; Pamuk ON; Erzin Y; Celik AF
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for Behçet's disease.
    Fresko I; Yazici H
    Expert Opin Pharmacother; 2008 Dec; 9(18):3211-9. PubMed ID: 19040341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.
    Leccese P; Ozguler Y; Christensen R; Esatoglu SN; Bang D; Bodaghi B; Celik AF; Fortune F; Gaudric J; Gül A; Kötter I; Mahr A; Moots RJ; Richter J; Saadoun D; Salvarani C; Scuderi F; Sfikakis PP; Siva A; Stanford M; Tugal-Tutkun I; West R; Yurdakul S; Olivieri I; Yazici H; Hatemi G
    Semin Arthritis Rheum; 2019 Feb; 48(4):752-762. PubMed ID: 29954598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in interferon: A treatment of Behcet syndrome].
    Yan D; Zheng WJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1166-1170. PubMed ID: 33331331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome.
    Ozguler Y; Hatemi G; Cetinkaya F; Tascilar K; Hamuryudan V; Ugurlu S; Seyahi E; Yazici H; Melikoglu M
    Rheumatology (Oxford); 2020 Apr; 59(4):799-806. PubMed ID: 31504957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the parenchymal neurological involvement and posterior uveitis in Behçet's syndrome.
    Bitik B; Tufan A; Sahin K; Sucullu Karadag Y; Can Sandikci S; Mercan R; Ak F; Karaaslan Y; Ozturk MA; Goker B; Haznedaroglu S
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):82-85. PubMed ID: 27791948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of vascular Behçet's disease.
    Alibaz-Oner F; Direskeneli H
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():105-108. PubMed ID: 29665281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behçet's syndrome: a critical digest of the 2014-2015 literature.
    Hatemi G; Seyahi E; Fresko I; Talarico R; Hamuryudan V
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S3-14. PubMed ID: 26487500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EULAR recommendations for the management of Behçet disease.
    Hatemi G; Silman A; Bang D; Bodaghi B; Chamberlain AM; Gul A; Houman MH; Kötter I; Olivieri I; Salvarani C; Sfikakis PP; Siva A; Stanford MR; Stübiger N; Yurdakul S; Yazici H;
    Ann Rheum Dis; 2008 Dec; 67(12):1656-62. PubMed ID: 18245110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Behcet's syndrome.
    Karadag O; Bolek EC
    Rheumatology (Oxford); 2020 May; 59(Suppl 3):iii108-iii117. PubMed ID: 32348509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet's Syndrome: A Strobe-Compliant Observational Study From a Dedicated Multidisciplinary Center.
    Hatemi I; Esatoglu SN; Hatemi G; Erzin Y; Yazici H; Celik AF
    Medicine (Baltimore); 2016 Apr; 95(16):e3348. PubMed ID: 27100417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.
    Desbois AC; Biard L; Addimanda O; Lambert M; Hachulla E; Launay D; Ackermann F; Pérard L; Hot A; Maurier F; Mausservey C; Bernard F; Noel N; Alric L; Mirault T; Cohen F; Boussouar S; Resche-Rigon M; Cacoub P; Saadoun D
    Clin Immunol; 2018 Dec; 197():54-59. PubMed ID: 30125675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.
    Hamuryudan V; Hatemi G; Tascilar K; Sut N; Ozyazgan Y; Seyahi E; Mat C; Yurdakul S; Yazici H
    Rheumatology (Oxford); 2010 Jan; 49(1):173-7. PubMed ID: 19995858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.
    Hatemi G; Silman A; Bang D; Bodaghi B; Chamberlain AM; Gul A; Houman MH; Kötter I; Olivieri I; Salvarani C; Sfikakis PP; Siva A; Stanford MR; Stübiger N; Yurdakul S; Yazici H
    Ann Rheum Dis; 2009 Oct; 68(10):1528-34. PubMed ID: 18420940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year in review 2018: Behçet's syndrome.
    Hatemi G; Seyahi E; Fresko I; Talarico R; Hamuryudan V
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):13-27. PubMed ID: 30582516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a questionnaire on the treatment of patients with Behçet's syndrome: a trend for more intensive treatment.
    Turkstra F; van Vugt RM; Dijkmans BA; Yazici Y; Yazici H
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S10-3. PubMed ID: 22776270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic vasculitis and the gut.
    Hatemi I; Hatemi G; Çelik AF
    Curr Opin Rheumatol; 2017 Jan; 29(1):33-38. PubMed ID: 27684357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.